Platelet gene expression and function in patients with COVID-19
暂无分享,去创建一个
Robert A. Campbell | A. Weyrich | C. Stubben | J. Rowley | N. Tolley | Aaron C Petrey | M. Rondina | M. Cody | B. Manne | E. Middleton | F. Denorme | Li Guo | I. Portier | C. Yost | Aaron C. Petrey | Chris Stubben
[1] M. Cecconi,et al. Humanitas COVID-19 Task Force Venous and Arterial Thromboembolic Complications in COVID-19 Patients Admitted to an Academic Hospital in Milan, Italy , 2020, Journal of Vascular Surgery: Venous and Lymphatic Disorders.
[2] Simon C Watkins,et al. Intravascular hemolysis triggers ADP-mediated generation of platelet-rich thrombi in pre-capillary pulmonary arterioles. , 2020, JCI insight.
[3] Qing Jun Wang,et al. Platelets Endocytose Viral Particles and Are Activated via TLR (Toll-Like Receptor) Signaling , 2020, Arteriosclerosis, thrombosis, and vascular biology.
[4] M. Trauner,et al. Pulmonary Arterial Thrombosis in COVID-19 With Fatal Outcome: Results From a Prospective, Single-Center, Clinicopathologic Case Series , 2020, Annals of Internal Medicine.
[5] Mickaël Ohana,et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study , 2020, Intensive Care Medicine.
[6] S. Farmer,et al. Characteristics of ischaemic stroke associated with COVID-19 , 2020, Journal of Neurology, Neurosurgery, and Psychiatry.
[7] D. Griffin,et al. Pulmonary Embolism and Increased Levels of D-Dimer in Patients with Coronavirus Disease , 2020, Emerging infectious diseases.
[8] J. Knight,et al. Interferon-Induced Transmembrane Protein 3 Genetic Variant rs12252-C Associated With Disease Severity in Coronavirus Disease 2019 , 2020, The Journal of infectious diseases.
[9] J. Connors,et al. COVID-19 and its implications for thrombosis and anticoagulation , 2020, Blood.
[10] Nils Kucher,et al. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy , 2020, Thrombosis Research.
[11] Norbert Stefan,et al. Obesity and impaired metabolic health in patients with COVID-19 , 2020, Nature Reviews Endocrinology.
[12] S. Susen,et al. Pulmonary Embolism in COVID-19 Patients: Awareness of an Increased Prevalence. , 2020, Circulation.
[13] M. Ramakers,et al. High incidence of venous thromboembolic events in anticoagulated severe COVID‐19 patients , 2020, Journal of Thrombosis and Haemostasis.
[14] P. Navalesi,et al. COVID-19-Related Severe Hypercoagulability in Patients Admitted to Intensive Care Unit for Acute Respiratory Failure , 2020, Thrombosis and Haemostasis.
[15] Yuan Yu,et al. Thrombocytopenia and its association with mortality in patients with COVID‐19 , 2020, Journal of Thrombosis and Haemostasis.
[16] Su Zhao,et al. Association between platelet parameters and mortality in coronavirus disease 2019: Retrospective cohort study , 2020, Platelets.
[17] D. Gommers,et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19 , 2020, Thrombosis Research.
[18] I. Ziogas,et al. Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past , 2020, Journal of Clinical Virology.
[19] G. B. Tan,et al. Hematologic parameters in patients with COVID‐19 infection , 2020, American journal of hematology.
[20] O. Borst,et al. Phospho‐inositide‐dependent kinase 1 regulates signal dependent translation in megakaryocytes and platelets , 2020, Journal of thrombosis and haemostasis : JTH.
[21] Robert A. Campbell,et al. Longitudinal RNA-Seq Analysis of the Repeatability of Gene Expression and Splicing in Human Platelets Identifies a Platelet SELP Splice QTL , 2019, Circulation research.
[22] Samuel M. Brown,et al. Sepsis Alters the Transcriptional and Translational Landscape of Human and Murine Platelets. , 2019, Blood.
[23] M. Rondina,et al. The Era of Thromboinflammation: Platelets Are Dynamic Sensors and Effector Cells During Infectious Diseases , 2019, Front. Immunol..
[24] S. Hsieh,et al. Extracellular vesicles from CLEC2-activated platelets enhance dengue virus-induced lethality via CLEC5A/TLR2 , 2019, Nature Communications.
[25] Robert A. Campbell,et al. Human megakaryocytes possess intrinsic antiviral immunity through regulated induction of IFITM3. , 2019, Blood.
[26] D. Levy,et al. The role of platelets in mediating a response to human influenza infection , 2019, Nature Communications.
[27] P. Tsai,et al. Dengue virus nonstructural protein 1 activates platelets via Toll-like receptor 4, leading to thrombocytopenia and hemorrhage , 2019, PLoS pathogens.
[28] A. Weyrich,et al. Persistent platelet activation and apoptosis in virologically suppressed HIV-infected individuals , 2018, Scientific Reports.
[29] P. D. de Groot,et al. Thrombocytopenia and Platelet Dysfunction in Acute Tropical Infectious Diseases , 2018, Seminars in Thrombosis and Hemostasis.
[30] Robert A. Campbell,et al. PDK1 governs thromboxane generation and thrombosis in platelets by regulating activation of Raf1 in the MAPK pathway , 2018, Journal of thrombosis and haemostasis : JTH.
[31] J. Freedman,et al. Circulating Platelets as Mediators of Immunity, Inflammation, and Thrombosis , 2018, Circulation research.
[32] Robert A. Campbell,et al. Granzyme A in Human Platelets Regulates the Synthesis of Proinflammatory Cytokines by Monocytes in Aging , 2018, The Journal of Immunology.
[33] Robert A. Campbell,et al. Clots Are Potent Triggers of Inflammatory Cell Gene Expression: Indications for Timely Fibrinolysis , 2017, Arteriosclerosis, thrombosis, and vascular biology.
[34] J. Mcfadyen,et al. Neutrophil macroaggregates promote widespread pulmonary thrombosis after gut ischemia , 2017, Science Translational Medicine.
[35] É. Boilard,et al. Mature murine megakaryocytes present antigen-MHC class I molecules to T cells and transfer them to platelets. , 2017, Blood advances.
[36] Gustavo A. Salazar,et al. Platelet proteome reveals novel pathways of platelet activation and platelet-mediated immunoregulation in dengue , 2017, PLoS pathogens.
[37] S. Bhattacharyya,et al. Platelet activation determines the severity of thrombocytopenia in dengue infection , 2017, Scientific Reports.
[38] V. Novakovic,et al. Phosphatidylserine-mediated platelet clearance by endothelium decreases platelet aggregates and procoagulant activity in sepsis , 2016, Scientific Reports.
[39] A. Weyrich,et al. Platelets in Pulmonary Immune Responses and Inflammatory Lung Diseases. , 2016, Physiological reviews.
[40] H. Weiner,et al. Platelets Play Differential Role During the Initiation and Progression of Autoimmune Neuroinflammation. , 2015, Circulation research.
[41] R. Storey,et al. The role of platelets in inflammation , 2015, Thrombosis and Haemostasis.
[42] É. Boilard,et al. Nouvelle Cuisine: Platelets Served with Inflammation , 2015, The Journal of Immunology.
[43] B. Nkambule,et al. Platelet leukocyte aggregates and markers of platelet aggregation, immune activation and disease progression in HIV infected treatment naive asymptomatic individuals , 2015, Journal of Thrombosis and Thrombolysis.
[44] J. Schneider,et al. Platelet activation and aggregation promote lung inflammation and influenza virus pathogenesis. , 2015, American journal of respiratory and critical care medicine.
[45] A. Assinger. Platelets and Infection – An Emerging Role of Platelets in Viral Infection , 2014, Front. Immunol..
[46] E. Benjamin,et al. Platelet-TLR7 mediates host survival and platelet count during viral infection in the absence of platelet-dependent thrombosis. , 2014, Blood.
[47] G. Paré,et al. Influenza virus H1N1 activates platelets through FcγRIIA signaling and thrombin generation. , 2014, Blood.
[48] J. Mankowski,et al. TGF&bgr;-Mediated Downregulation of Thrombopoietin Is Associated With Platelet Decline in Asymptomatic SIV Infection , 2014, Journal of acquired immune deficiency syndromes.
[49] C. Díaz-Torné,et al. Functional consequences of platelet binding to T lymphocytes in inflammation , 2013, Journal of leukocyte biology.
[50] J. Lopez-Delgado,et al. Thrombocytopenia as a mortality risk factor in acute respiratory failure in H1N1 influenza. , 2013, Swiss medical weekly.
[51] A. Chishti,et al. Dual Mechanism of Integrin αIIbβ3 Closure in Procoagulant Platelets* , 2013, The Journal of Biological Chemistry.
[52] E. Podrez,et al. Engagement of Platelet Toll-Like Receptor 9 by Novel Endogenous Ligands Promotes Platelet Hyperreactivity and Thrombosis , 2013, Circulation research.
[53] B. Engelmann,et al. Thrombosis as an intravascular effector of innate immunity , 2012, Nature Reviews Immunology.
[54] R. Flaumenhaft,et al. T granules in human platelets function in TLR9 organization and signaling , 2012, The Journal of cell biology.
[55] W. Baldwin,et al. Platelets Present Antigen in the Context of MHC Class I , 2012, The Journal of Immunology.
[56] Z. Werb,et al. Platelets induce neutrophil extracellular traps in transfusion-related acute lung injury. , 2012, The Journal of clinical investigation.
[57] V. Regitz-Zagrosek,et al. Pulmonary Arterial Thrombosis in COVID-19 With Fatal Outcome , 2012, Annals of Internal Medicine.
[58] A. Weyrich,et al. In vivo platelet activation in critically ill patients with primary 2009 influenza A(H1N1). , 2012, Chest.
[59] A. Fauci,et al. Identification of the platelet-derived chemokine CXCL4/PF-4 as a broad-spectrum HIV-1 inhibitor , 2012, Proceedings of the National Academy of Sciences.
[60] C. Tyler-Smith,et al. IFITM3 restricts the morbidity and mortality associated with influenza , 2012, Nature.
[61] Robert A. Campbell,et al. Novel Anti-bacterial Activities of β-defensin 1 in Human Platelets: Suppression of Pathogen Growth and Signaling of Neutrophil Extracellular Trap Formation , 2011, PLoS pathogens.
[62] Robert A. Campbell,et al. The septic milieu triggers expression of spliced tissue factor mRNA in human platelets , 2011, Journal of thrombosis and haemostasis : JTH.
[63] J. Freedman,et al. Platelets and the immune continuum , 2011, Nature Reviews Immunology.
[64] J. Lambert,et al. Platelet function and HIV: a case–control study , 2010, AIDS.
[65] R. Flaumenhaft,et al. Platelet alpha-granules: basic biology and clinical correlates. , 2009, Blood reviews.
[66] P. Flevaris,et al. Two distinct roles of mitogen-activated protein kinases in platelets and a novel Rac1-MAPK-dependent integrin outside-in retractile signaling pathway. , 2009, Blood.
[67] Chi-kong Li,et al. Thrombopoietin levels increased in patients with severe acute respiratory syndrome , 2008, Thrombosis Research.
[68] K. Ley,et al. Complete reversal of acid-induced acute lung injury by blocking of platelet-neutrophil aggregation. , 2006, The Journal of clinical investigation.
[69] G. Deuschl,et al. Platelet–Leukocyte Interaction and Platelet Activation in Acute Stroke With and Without Preceding Infection , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[70] J. Chou,et al. Accumulation of Tissue Factor into Developing Thrombi In Vivo Is Dependent upon Microparticle P-Selectin Glycoprotein Ligand 1 and Platelet P-Selectin , 2003, The Journal of experimental medicine.
[71] M. Selsted,et al. Antimicrobial Peptides from Human Platelets , 2002, Infection and Immunity.
[72] Dan Zhu,et al. Role of a JAK3-dependent Biochemical Signaling Pathway in Platelet Activation and Aggregation* , 2001, The Journal of Biological Chemistry.
[73] D. Kuter,et al. The platelet thrombopoietin receptor number and function are markedly decreased in patients with essential thrombocythaemia , 2000, British journal of haematology.
[74] W. Farrar,et al. JAK3, STAT, and MAPK signaling pathways as novel molecular targets for the tyrphostin AG-490 regulation of IL-2-mediated T cell response. , 1999, Journal of immunology.
[75] Y. Matsuzawa,et al. Markedly reduced expression of platelet c-mpl receptor in essential thrombocythemia. , 1997, Blood.
[76] A. Gurney,et al. Regulation of thrombopoietin levels by c-mpl-mediated binding to platelets. , 1996, Blood.
[77] C. Stiles,et al. Platelet alpha granules contain a growth factor for fibroblasts. , 1979, Blood.